Design, Multigram Synthesis, and in Vitro and in Vivo Evaluation of Propylamycin: A Semisynthetic 4,5-Deoxystreptamine Class Aminoglycoside for the Treatment of Drug-Resistant Enterobacteriaceae and Other Gram-Negative Pathogens

Documenti analoghi

• Use of a fluorescence assay to determine relative affinities of semisynthetic aminoglycosides to small RNAs representing bacterial and mitochondrial A sites
  di: Waduge, Prabuddha, et al.
  Pubblicazione: (2019)
• Modification at the 2′-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics To Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target Selectivity
  di: Sati, Girish C., et al.
  Pubblicazione: (2019)
• Stereospecific Synthesis of Methyl 2-Amino-2,4-dideoxy-6S-deuterio-α-D-xylo-hexopyranoside and Methyl 2-Amino-2,4-dideoxy-6S-deuterio-4-propyl-α-D-glucopyranoside: Side Chain Conformation of the Novel Aminoglycoside Antibiotic Propylamycin.
  di: Pirrone, Michael G., et al.
  Pubblicazione: (2020)
• Synthesis of a Pseudodisaccharide Suitable for Synthesis of Ring I Modified 4,5–2-Deoxystreptamine Type Aminoglycoside Antibiotics.
  di: Sonousi, Amr, et al.
  Pubblicazione: (2020)
• N6′, N6‴, and O4′-Modifications to Neomycin Affect Ribosomal Selectivity Without Compromising Antibacterial Activity
  di: Sati, Girish C., et al.
  Pubblicazione: (2017)